Umemoto A, Monden Y, Tsuda M, Grivas S, Sugimura T
Biochemistry Division, National Cancer Center Research Institute, Tokyo, Japan.
Biochem Biophys Res Commun. 1988 Mar 30;151(3):1326-31. doi: 10.1016/s0006-291x(88)80507-2.
The binding to hemoglobin of synthetic 2-hydroxyamino-6-methyldipyrido[1,2-a: 3',2'-d] imidazole from the carcinogenic product of L-glutamic acid pyrolysis 2-amino-6-methyldipyrido[1,2-a: 3',2'-d] imidazole were investigated in vitro. The hydroxylamine required oxidation to its nitroso derivative to bind to rat hemoglobin through thiol groups. Oxidation of the hydroxylamine to the nitroso form was found to be enhanced by oxyhemoglobin and superoxide dismutase at pH 7.4 under aerobic conditions. Since these conditions might also enhance this oxidation in vivo, the conversion of the DNA-reactive arylhydroxylamines to the DNA-non-reactive nitroso compounds and their subsequent binding to highly abundant thiol groups of proteins could be considered as a process for detoxification of toxic arylhydroxylamines.
对来自L-谷氨酸热解致癌产物2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑的合成2-羟基氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑与血红蛋白的结合进行了体外研究。羟胺需要氧化成其亚硝基衍生物才能通过硫醇基团与大鼠血红蛋白结合。发现在有氧条件下,pH 7.4时,氧合血红蛋白和超氧化物歧化酶可增强羟胺氧化成亚硝基形式的过程。由于这些条件在体内也可能增强这种氧化作用,因此可将具有DNA反应性的芳基羟胺转化为无DNA反应性的亚硝基化合物及其随后与蛋白质中高度丰富的硫醇基团的结合视为有毒芳基羟胺的解毒过程。